IL130822A - N-acyl phosphatidylethanolamine-mediated liposomaldrug delivery - Google Patents

N-acyl phosphatidylethanolamine-mediated liposomaldrug delivery

Info

Publication number
IL130822A
IL130822A IL13082297A IL13082297A IL130822A IL 130822 A IL130822 A IL 130822A IL 13082297 A IL13082297 A IL 13082297A IL 13082297 A IL13082297 A IL 13082297A IL 130822 A IL130822 A IL 130822A
Authority
IL
Israel
Prior art keywords
delivery
liposomaldrug
mediated
acyl phosphatidylethanolamine
phosphatidylethanolamine
Prior art date
Application number
IL13082297A
Other languages
English (en)
Other versions
IL130822A0 (en
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of IL130822A0 publication Critical patent/IL130822A0/xx
Publication of IL130822A publication Critical patent/IL130822A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
IL13082297A 1996-10-15 1997-10-15 N-acyl phosphatidylethanolamine-mediated liposomaldrug delivery IL130822A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2855796P 1996-10-15 1996-10-15
PCT/US1997/018112 WO1998016199A1 (en) 1996-10-15 1997-10-15 N-acyl phosphatidylethanolamine-mediated liposomal drug delivery

Publications (2)

Publication Number Publication Date
IL130822A0 IL130822A0 (en) 2001-07-24
IL130822A true IL130822A (en) 2005-12-18

Family

ID=21844115

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13082297A IL130822A (en) 1996-10-15 1997-10-15 N-acyl phosphatidylethanolamine-mediated liposomaldrug delivery

Country Status (13)

Country Link
US (2) US6120797A (de)
EP (1) EP0966267B1 (de)
AT (1) ATE423547T1 (de)
AU (1) AU725257B2 (de)
CA (1) CA2276269C (de)
DE (1) DE69739277D1 (de)
ES (1) ES2321769T3 (de)
HU (1) HUP0000522A3 (de)
IL (1) IL130822A (de)
NO (1) NO993257L (de)
NZ (2) NZ514133A (de)
SK (1) SK283760B6 (de)
WO (1) WO1998016199A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2343767T3 (es) 1997-09-18 2010-08-09 Pacira Pharmaceuticals, Inc. Composiciones anestesicas liposomicas de liberacion sostenida.
WO1999025319A1 (en) 1997-11-14 1999-05-27 Depotech Corporation Production of multivesicular liposomes
CA2338031C (en) 1998-07-17 2006-12-05 Sankaram Bhima Mantripragada Biodegradable compositions for the controlled release of encapsulated substances
EP1419252A2 (de) * 2001-04-04 2004-05-19 Merrion Research I Limited Genetische analyse der peyer'schen plaques und m zellen und verfahren und zusammensetzungen zur targeting der peyer'schen plaques und m zellen
CA2447990C (en) * 2001-05-31 2012-01-31 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
EP1461014B1 (de) * 2001-12-04 2021-07-14 Ben Gurion University Of The Negev Research And Development Authority Amphiphile verbindungen und vesikel/liposome für das organspezifische arzneimittel-targeting
CA2471918A1 (en) * 2002-01-09 2003-07-24 Elan Pharmaceuticals, Inc. Efficient liposomal encapsulation under mild conditions
US20060058249A1 (en) * 2002-01-09 2006-03-16 Shangguan Tong Efficient nucleic acid encapsulation into medium sized liposomes
EP1471885A4 (de) * 2002-01-09 2009-04-22 Transave Inc Wirkungsvolle liposom-verkapselung
AU2003226974A1 (en) * 2002-02-12 2003-09-04 Hunza Di Pistolesi Elvira And C. S.A.S. N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
AU2003241598B2 (en) * 2002-07-02 2009-11-05 Nanotx Corp. Radiolabeled compounds and liposomes and their methods of making and using the same
ITMI20021455A1 (it) * 2002-07-02 2004-01-02 Ugo Raffaello Citernesi Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico
KR20060054405A (ko) * 2003-07-31 2006-05-22 더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 암, 암의 발병 또는 암 증상의 치료, 예방 및/또는 개선용조성물 및 방법
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
ITMI20041280A1 (it) * 2004-06-24 2004-09-24 Hunza Di Pistolesi Elvira & C Preparazione farmaceutiche dietetiche e-o cosmetiche per il trattamento dell'obesita' dell'alopecia della cellulite e dell'invecchiamento cutaneo
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
CA2622441A1 (en) * 2005-09-27 2007-04-05 Amunix, Inc. Proteinaceous pharmaceuticals and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
ES2530526T3 (es) 2005-12-30 2015-03-03 Zensun Shanghai Science And Technology Ltd Liberación extendida de neurregulina para mejorar la función cardíaca
WO2008030818A2 (en) * 2006-09-05 2008-03-13 Mebiopharm Co., Ltd. Novel liposome compositions
US8193246B2 (en) * 2006-12-19 2012-06-05 Marina Biotech, Inc. Lipids and lipid assemblies comprising transfection enhancer elements
EP2185701A4 (de) * 2007-08-15 2011-03-02 Amunix Operating Inc Zusammensetzungen und verfahren zur veränderung von eigenschaften biologisch aktiver polypeptide
EP2294073A1 (de) * 2008-07-08 2011-03-16 Chemi SPA Verfahren zur herstellung von n-acyl-phosphatidylethanolamin
CA2748314C (en) 2009-02-03 2018-10-02 Amunix Operating Inc. Extended recombinant polypeptides and compositions comprising same
DK2440228T3 (en) 2009-06-08 2018-12-17 Amunix Operating Inc Glucose regulating polypeptides and methods for their preparation and use
SG10201704777RA (en) 2009-06-08 2017-07-28 Amunix Operating Inc Growth hormone polypeptides and methods of making and using same
AU2010290131C1 (en) 2009-08-24 2015-12-03 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
CN106619515A (zh) * 2009-08-27 2017-05-10 工业研究与发展基金会有限公司 脂质体组合物及其用途
WO2011053675A2 (en) 2009-10-30 2011-05-05 Cns Therapeutics, Inc. Improved neurturin molecules
WO2012094727A1 (en) * 2010-10-29 2012-07-19 The Governing Council Of The University Of Toronto Lipid encapsulation of surface enhanced raman scattering (sers) nanoparticles
DK2822577T3 (en) 2012-02-15 2019-04-01 Bioverativ Therapeutics Inc RECOMBINANT FACTOR VIII PROTEINS
ES2771208T3 (es) 2012-02-15 2020-07-06 Bioverativ Therapeutics Inc Composiciones de factor VIII y métodos de preparación y uso de las mismas
WO2015023891A2 (en) 2013-08-14 2015-02-19 Biogen Idec Ma Inc. Factor viii-xten fusions and uses thereof
AU2015236106A1 (en) 2014-03-25 2016-10-20 The Government Of The United States Of America As Represented By The Secretary Of The Army Non-toxic adjuvant formulation comprising a monophosphoryl lipid a (MPLA)-containing liposome composition and a saponin
WO2017024060A1 (en) 2015-08-03 2017-02-09 Biogen Ma Inc. Factor ix fusion proteins and methods of making and using same
WO2017079582A1 (en) 2015-11-06 2017-05-11 Adjuvance Technologies, Inc. Triterpene saponin analogues
WO2018071679A1 (en) * 2016-10-13 2018-04-19 Carnot, Llc N-acylethanolamide derivatives and uses thereof
WO2018208728A1 (en) 2017-05-08 2018-11-15 Flagship Pioneering, Inc. Compositions for facilitating membrane fusion and uses thereof
WO2019079160A1 (en) 2017-10-16 2019-04-25 Adjuvance Technologies, Inc. TRITERPENIC SAPONIN ANALOGS
NZ769677A (en) 2018-05-18 2024-07-05 Bioverativ Therapeutics Inc Methods of treating hemophilia a
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
IL314731A (en) 2022-03-14 2024-10-01 Pfizer Additive manufacturing methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents

Also Published As

Publication number Publication date
AU725257B2 (en) 2000-10-12
NZ514133A (en) 2001-09-28
SK99399A3 (en) 2000-06-12
IL130822A0 (en) 2001-07-24
DE69739277D1 (de) 2009-04-09
EP0966267A4 (de) 2006-02-01
CA2276269C (en) 2008-09-02
US6120797A (en) 2000-09-19
US6294191B1 (en) 2001-09-25
ATE423547T1 (de) 2009-03-15
AU4672397A (en) 1998-05-11
NZ336538A (en) 2001-11-30
NO993257L (no) 1999-07-28
NO993257D0 (no) 1999-06-30
HUP0000522A3 (en) 2000-10-30
WO1998016199A1 (en) 1998-04-23
SK283760B6 (sk) 2004-01-08
EP0966267B1 (de) 2009-02-25
HUP0000522A1 (hu) 2000-09-28
ES2321769T3 (es) 2009-06-10
EP0966267A1 (de) 1999-12-29
CA2276269A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
IL130822A (en) N-acyl phosphatidylethanolamine-mediated liposomaldrug delivery
MX9700789A (es) Composicion curativa bioadhesiva para heridas.
BG104247A (en) Resorcinol derivatives
AP9901534A0 (en) Pharmaceutical formulations.
MY134559A (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
EP0772590A4 (de) Thrombin-inhibitoren
TNSN97010A1 (fr) Cyclopentanopyridyl-oxazolidinones contenant des heteroatomes.
IL109720A0 (en) N-alkylthio polyamide derivatives as radioprotective agents
HK1034523A1 (en) Hemiasterlin analogs
GR3025368T3 (en) Non active substance containing liposomes for the treatment of atherosclerosis
SE9802937D0 (sv) Novel compounds
MY112148A (en) Suspension concentrate compositions of arylpyrrole insecticidal and acarricidal agents
CA2284142A1 (en) Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
EP1073447A4 (de) N1 modifizierte glycopeptide
EP0540574A4 (de)
GR3034406T3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
DE50208813D1 (en) (ester)-lysolecithine in liposomen
ZA96901B (en) 6-heterocyclyl-1-(substituted phenyl) benzotriazole herbicidal agents.
AP2000001746A0 (en) Anti- first-pass effect compounds.
EP1082967A4 (de) Prophylaxe und behandlung von autoimmunen entmarkungskrankheiten
DE69929802D1 (en) Lta4 hydrolase-hemmer
MX9602767A (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina.
MA24992A1 (fr) Produits multimineraux utiles pour l'equilibre neurovegetatif.
UA31206A (uk) Речовина 1,1-(2"-бром-2"-хлоретенил)-біс-(5-фторурацил)-у , яка має протипухлинну активність
WO1999015198A3 (de) Mittel gegen bakterielle meningitis

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees